WMW demonstrates effectiveness in reducing NAFLD progression in mice, suggesting potential for clinical applications.
WMW demonstrates significant efficacy against NAFLD, likely through multi-target reprogramming of hepatic metabolism. These findings position WMW as a promising phytopharmaceutical candidate worthy of further clinical investigation.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: